CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the ...
Hosted on MSN
The Lost Art of Mounting the Beam...
Their 'One That Got Away' Married Someone Else. This Was The Hardest Thing To Accept. Detective says Melissa Perez was not close to officers when they fired at her 40 million Americans at risk of ...
Beam Therapeutics Inc. (NASDAQ:BEAM) ranks among the best CRISPR stocks to buy. On June 13, Beam Therapeutics Inc. (NASDAQ:BEAM) announced new efficacy and safety findings from its BEACON Phase 1/2 ...
CAMBRIDGE, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the ...
Beam Therapeutics is set to present positive and significant data from the BEACON Phase 1/2 clinical trial of BEAM-101 at a major conference, enhancing visibility and credibility within the scientific ...
Beam Therapeutics has announced significant progress in its clinical trials and portfolio regarding precision genetic medicines, particularly in the area of sickle cell disease (SCD). Over 40 adult ...
StoreDot unveils its I-BEAM XFC concept, a cell-to-pack design that takes extreme fast charging (XFC) from cell to vehicle level. At the concept’s core, StoreDot’s 100in5 electrodes are assembled into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback